Apr 22, 2026

Email 1:

Subject: An ER doctor’s ketamine journey and the AI therapy loopholes

Summary: This newsletter from KevinMD features an ER doctor’s personal story of severe burnout and depression, highlighting the positive impact of IV ketamine treatment after traditional antidepressants failed. It also discusses Illinois’ new law banning AI therapy chatbots with exemptions for physicians, raising informed consent concerns. Additional articles cover women’s struggles with work-life balance in medicine, modernizing healthcare with AI, Medicare’s need to embrace AI for senior mental health, the importance of testing for Lp(a) to assess heart risk, physician burnout, recognition of medical veterans, physician entrepreneurship, physician leadership in AI vetting, repeal of hospital monopolies in South Carolina, and the drawbacks of the 15-minute doctor appointment.

Sender: newsletter@kevinmd.com

Email 2:

Subject: We’res

Summary: Happiful announces a special edition of its magazine featuring a cover illustrated by a world-renowned artist alongside their resident illustrator Rosan Magar, who embraces the fresh artistic perspective. Readers are invited to read an interview with Rosan about his inspirations and the cover’s creation process. The issue is available from May 1 and can be subscribed to now, with delivery guaranteed. Happiful promotes mental wellbeing through diverse perspectives and aims to provide monthly support with trusted advice and inspiring content.

Sender: hello@happiful.com

Email 3:

Subject: This CDC conference was always open to the public. Until now.

Summary: STAT Morning Rounds reports that the CDC’s annual Epidemic Intelligence Service conference, usually public, is now restricted due to budget cuts and takes place on the CDC campus with limited access. The newsletter covers President Trump’s executive order easing restrictions on psychedelic drugs, which has sparked enthusiasm and concern among experts. Also covered is a federal judge’s ruling against Robert F. Kennedy Jr.’s gender-affirming care declaration, the role of a CEO’s executive functions in a new opinion essay, and a study revealing that some food-insecure children fall outside SNAP eligibility. Additional science, health, and policy updates are provided.

Sender: newsletter@statnews.com

Email 4:

Subject: 💊 Pharma deal exclusives

Summary: Axios Vitals reports intensifying Democratic scrutiny of President Trump’s drug pricing deals, with Senate Democrats planning legislation requiring transparency on terms with pharmaceutical companies. UnitedHealthcare plans to reduce pre-treatment claim reviews for about 1,500 rural hospitals to ease burdens. The FBI urges hospitals to share cyberthreat intelligence to combat rising cyberattacks, especially ransomware targeting healthcare. Prescription data shows a 21.7% increase in first-time GLP-1 drug prescriptions, including weight loss medications Wegovy and Mounjaro. The newsletter also covers setbacks in HIV programs, Eli Lilly’s acquisition in CAR-T therapy, and Oscar Health’s new marketplace.

Sender: vitals@axios.com

Email 5:

Subject: Should we worry about AI doomsday?

Summary: Nature Briefing explores concerns about doomsday scenarios from powerful autonomous AI, noting that while risks exist, evidence for human extinction is scant. AI-powered social network Agent4Science allows AI agents to discuss research autonomously, highlighting experimentation in AI science communication. A 33-year trial in Tanzania shows children living in architecturally designed “Star Homes” experience fewer malaria and infections. The FDA proposes rethinking personalized CRISPR therapies to enable broader treatment access. The briefing also addresses the welfare of aquatic animals, nuclear safety lessons, and includes a thought-provoking quote on innovation versus regulation.

Sender: briefing@nature.com

Email 6:

Subject: Reminder: Tune in Thursday for a live AACR recap + stop by tonight’s

Summary: STAT announces two AACR (American Association for Cancer Research) events: a live interactive recap on April 23rd covering conference highlights, studies, and future trends in cancer care, and an in-person gathering in San Diego featuring prominent speakers and networking opportunities with drinks and light bites. Attendees are encouraged to RSVP or drop by to engage with STAT’s editorial team and colleagues from the cancer research community.

Sender: marketing@statnews.com

Stay Well!